India Stock Board Noted Trading Spike Before Sun-Ranbaxy Deal Revealed
This article was originally published in PharmAsia News
Executive Summary
The sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries appears to have been preceded by an unusual amount of stock market trading, prompting the responsible India agency to take a look.